Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
8,477
Total Claims
$989K
Drug Cost
930
Beneficiaries
$1,063
Cost/Patient
Risk Score Breakdown 21/100
Score components are additive. Read full methodology
Peer Comparison vs. 3,186 Anesthesiology providers
+76%
Opioid rate vs peers
61.2% vs 34.8% avg
+152%
Cost per patient vs peers
$1,063 vs $422 avg
+122%
Brand preference vs peers
10.5% vs 4.7% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
61.2%
Opioid Rate
5,190
Opioid Claims
$788K
Opioid Cost
39.9%
Long-Acting Rate
This provider's opioid prescribing rate of 61.2% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 889 claims · $619K
Generic: 7,588 claims · $369K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Buprenorphine Hcl | 375 | $338K |
| Buprenorphine | 554 | $189K |
| Oxycodone Myristate | 140 | $79K |
| Levorphanol Tartrate | 13 | $44K |
| Buprenorphine | 55 | $40K |
| Tapentadol Hcl | 29 | $30K |
| Methylnaltrexone Bromide | 11 | $29K |
| Gabapentin | 1,094 | $24K |
| Pregabalin | 468 | $22K |
| Naloxegol Oxalate | 37 | $20K |
| Oxycodone Hcl | 20 | $17K |
| Oxycodone Hcl/Acetaminophen | 927 | $17K |
| Tramadol Hcl | 147 | $13K |
| Morphine Sulfate | 486 | $11K |
| Hydrocodone/Acetaminophen | 544 | $11K |
Prescribing Profile
41
Unique Drugs
21.0
Anomaly Score
Patient Profile
71
Avg Age
64%
Female
1.67
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About